Consultation on Edible Cannabis, Cannabis Extracts and Cannabis Topicals

Health Canada is launching a public consultation on draft regulations addressing additional cannabis products, namely edible cannabis, cannabis extracts and cannabis topicals.

The proposed Regulations Amending the Cannabis Regulations and Regulatory Impact Analysis Statement (RIAS) is published in the Canada Gazette, Part I, on December 22, 2018.

You can obtain a copy of the proposed regulations and RIAS by sending an email to cannabis@canada.ca

The Cannabis Regulations, which also came into force on October 17, 2018, established the rules and standards that apply to the authorized production, distribution, sale, importation and exportation of cannabis (with the exception of industrial hemp), as well as other related activities respecting the five classes of cannabis (i.e. dried cannabis, fresh cannabis, cannabis oil, cannabis plants, and cannabis plant seeds) that can be sold by authorized persons.

Health Canada is seeking feedback on the proposed regulations to minimize the public health and public safety risks posed by (i) edible cannabis, (ii) cannabis extracts; and, (iii) cannabis topicals.  These cannabis products will be permitted for legal sale under the Cannabis Act no later than October 17, 2019.

Health Canada will accept comments for 60 days; the comment period closing February 20-2019

For more information on the proposed regulations, please see the Backgrounder: Consultation on the strict regulation of edible cannabis, cannabis extracts and cannabis topicals.

Providing comments to Health Canada

Feedback can be provided to Health Canada through two means (i) an on-line questionnaire or (ii) comments in writing. Information or a link to both is provided below.

On-line Questionnaire

You can complete the Health Canada on-line questionnaire

Use the online form (you will not need to sign up for an account or give personal information)

You may also read, download or print the consultation questions.

Written submissions

Written comments can be submitted to Health Canada by email to cannabis@canada.ca